Why the study?
Does depression reduce adequate or optimal adherence to medications essential to guideline-directed medical therapies in patients following percutaneous coronary intervention?
Does depression reduce adequate or optimal adherence to medications essential to guideline-directed medical therapies in patients following percutaneous coronary intervention?
Depression is associated with lower adherence to guideline-directed medical therapies after PCI, highlighting the need for its recognition to improve secondary cardiovascular disease prevention.
Answers are grounded in this paper and cite their sources.
Depression associated with lower post-PCI GDMT adherence; hypothesis-generating for screening or interventions, does not yet change practice.
In this cohort study, patients with depression were less likely to achieve adequate or optimal adherence to medications essential to guideline-directed medical therapies following percutaneous coronary intervention compared with those without depression. Recognition of depression may facilitate targeted interventions to address medication adherence and thereby improve secondary cardiovascular disease prevention.
No takes yet. Share an insight, caveat, or question.
Lapa et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: